GLOBAL MED TECHNOLOGIES INC 3
3 · GLOBAL MED TECHNOLOGIES INC · Filed Apr 1, 2010
Insider Transaction Report
Form 3
HAEMONETICS CORP
10% Owner
Holdings
- (indirect: See Footnote)
Series A Convertible Preferred Stock
Exercise: $0.72→ Common Stock (5,500,000 underlying) - 31,428,730(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The reported securities are owned indirectly by Haemonetics Corporation ("Haemonetics") and directly by Atlas Acquisition Corp. ("Atlas"), a wholly-owned subsidiary of Haemonetics. The reported securities were acquired by Atlas in connection with the cash tender offer to purchase all outstanding shares of convertible preferred stock and Common Stock of the Issuer commenced by Atlas on February 19, 2010.
- [F2]Subject to the "blocker" provisions described in footnote 3, the convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.
- [F3]The convertible preferred stock is subject to "blocker" provisions prohibiting the holder from converting the preferred stock to the extent that such conversion would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of the Common Stock.
- [F4]Subject to the "blocker" provisions described in footnote 3, the shares of convertible preferred stock are convertible at a rate of 1-to-1,388.89 into the number of shares of Common Stock shown in column 3.